|Articles|June 15, 2015
ERT's MasterScope® 2 Deployed in Respiratory Clinical Trials
ERT, a global provider of patient safety and efficacy endpoint data collection, cloud analytics and workflow solutions, announced that MasterScope® 2, its comprehensive diagnostic platform for spirometry, electrocardiogram (ECG) and home monitoring, has been successfully implemented with 350 investigative sites.
Advertisement
ERT, a global provider of patient safety and efficacy endpoint data collection, cloud analytics and workflow solutions, announced that MasterScope® 2, its comprehensive diagnostic platform for spirometry, electrocardiogram (ECG) and home monitoring, has been successfully implemented with 350 investigative sites currently enrolling patients using the advancedMasterScope 2 platform. The platform collects processes trial endpoint data for spirometry combined with ERT’s AM3 GSM home spirometry, eDiary and the new, integrated12-lead digital ECG. One study is also taking advantage of MasterScope’s seamless integration of the Aerocrine NIOX Mino® capturing exhaled nitric oxide (FeNO).
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- How AI Can Help Physicians Identify Eligible Trials Faster
September 5th 2025
Advertisement
Advertisement